Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Public ClinicalTrials.gov record NCT02093962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2, Double-blind, Placebo-controlled, Multi-center Study Comparing Pemetrexed in Combination With TH-302 vs. Pemetrexed in Combination With Placebo as Second-line Chemotherapy for Advanced Non-Squamous, Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether TH-302 in combination with pemetrexed is safe and effective in the treatment of non-squamous non-small cell lung cancer.
Study identification
- NCT ID
- NCT02093962
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 265 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2014
- Primary completion
- Mar 31, 2016
- Completion
- Apr 30, 2016
- Last update posted
- May 15, 2025
2014 – 2016
United States locations
- U.S. sites
- 29
- U.S. states
- 21
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Cancer Center | Birmingham | Alabama | 35294 | — |
| Ironwood Cancer and Research Centers | Chandler | Arizona | 85224 | — |
| California Cancer Center | Encinitas | California | 92024 | — |
| California Cancer Center Associates | Fresno | California | 93720 | — |
| UCLA-Department of Medicine a Division of Hem/Onc | Los Angeles | California | 90095 | — |
| Sarcoma Oncology Research Center | Santa Monica | California | 90403 | — |
| VA Eastern Colorado Healthcare System | Denver | Colorado | 80220 | — |
| Christiana Care Health Services | Newark | Delaware | 19713 | — |
| Cancer Specialists of North Florida - CBO | Jacksonville Beach | Florida | 32256 | — |
| AMPM Research | Miami | Florida | 33133 | — |
| Research Medical Center | Kansas City | Kansas | 64132 | — |
| Ochsner Clinical Foundation | New Orleans | Louisiana | 70121 | — |
| Walter Reed National Military Medical Center | Bethesda | Maryland | 20889 | — |
| St. Joseph Mercy Ann Arbor Cancer Center | Ann Arbor | Michigan | 48106 | — |
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | — |
| Clinical Research Alliance | New York | New York | 10021 | — |
| Montefire-Einstein Center for Cancer Care | The Bronx | New York | 10461 | — |
| Durham VA Medical Center | Durham | North Carolina | 27705 | — |
| W.G. (Bill) Hefner VA Medical Center | Salisbury | North Carolina | 28144 | — |
| Gabrail Cancer Center Research | Canton | Ohio | 44718 | — |
| Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| DORN VA Medical Center | Columbia | South Carolina | 29209 | — |
| Regional Cancer Care Institute at Regional Health | Rapid City | South Dakota | 57701 | — |
| Associates in Oncology & Hematology | Chattanooga | Tennessee | 37421 | — |
| San Antonio Military Medical Center | Fort Sam Houston | Texas | 78234 | — |
| Oncology Consultants | Houston | Texas | 77024 | — |
| Millennium Oncology | Houston | Texas | 77090 | — |
| Fpr Belvoir Community Hospital | Fort Belvoir | Virginia | 22060 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02093962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02093962 live on ClinicalTrials.gov.